CLEAR-CELL METASTATIC RENAL CELL CARCINOMA
Clinical trials for CLEAR-CELL METASTATIC RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR-CELL METASTATIC RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR-CELL METASTATIC RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for untreated kidney cancer patients in pfizer trial
Disease control Recruiting nowThis study is testing a new medicine called PF-08634404 for adults with advanced kidney cancer that has spread. Researchers want to see if the medicine is safe and effective when given alone or with other cancer drugs. The study is recruiting 224 adults who haven't received any t…
Matched conditions: CLEAR-CELL METASTATIC RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC
-
New dosing strategy aims to make cancer treatment more tolerable
Disease control Recruiting nowThis study is testing a more flexible way to give the cancer drug cabozantinib to people with advanced kidney cancer or neuroendocrine tumors. The goal is to see if adjusting the dose up or down based on how patients feel can help them stay on treatment longer with fewer severe s…
Matched conditions: CLEAR-CELL METASTATIC RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC